LY3819253 & LY3832479 COVID-19: Clinical Study
Study is to measure how well LY3819253 and LY3832479 work against the virus that causes COVID-19.

Type of Study:
Adults 18 years and older with mild to moderate COVID-19 illness

Study Length:
12 weeks

Target Age/Sex:
18 years and older, Male and Female

Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures

Link: ClinicalTrials.gov

Staus: Enrolling

Description:

The purpose of this study is to measure how well LY3819253 and LY3832479 work against the virus that causes COVID-19.

LY3819253 and LY3832479 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus is in the body at various times during the study. Participation could last about 12 weeks and includes one required visit to the study site, with the remainder of assessments performed on site or by phone.

Enroll Now

Enroll Now

Address
Address
City
State/Province
Zip/Postal
If you don't have a primary care physician, just type "Do not have a primary care physician"